RT Journal Article
SR Electronic
T1 Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont <em>et al</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004347
DO 10.1136/jitc-2021-004347
VO 10
IS 1
A1 Weber, Jeffrey
A1 Mandala, Mario
A1 Ascierto, Paolo Antonio
A1 Larkin, James
YR 2022
UL http://jitc.bmj.com/content/10/1/e004347.abstract